Literature DB >> 14551309

From access to evidence: an advocate's journey.

Musa Mayer1.   

Abstract

Mesh：

Year:  2003        PMID： 14551309     DOI： 10.1200/JCO.2003.07.217

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Development and use of new therapeutics for rare diseases: views from patients, caregivers, and advocates.

Authors:  Aaron S Kesselheim; Sarah McGraw; Lauren Thompson; Kelly O'Keefe; Joshua J Gagne
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

Review 2.  Patient empowerment as a component of health system reforms: rights, benefits and vested interests.

Authors:  Cinzia Colombo; Lorenzo Moja; Marien Gonzalez-Lorenzo; Alessandro Liberati; Paola Mosconi
Journal:  Intern Emerg Med       Date:  2012-01-26       Impact factor: 3.397

3.  PartecipaSalute, an Italian project to involve lay people, patients' associations and scientific-medical representatives in the health debate.

Authors:  Paola Mosconi; Cinzia Colombo; Roberto Satolli; Alessandro Liberati
Journal:  Health Expect       Date:  2007-06       Impact factor: 3.377

4.  When clinical trials are compromised: a perspective from a patient advocate.

Authors:  Musa Mayer
Journal:  PLoS Med       Date:  2005-10-18       Impact factor: 11.069

Review 5.  Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?

Authors:  Courtney Davis
Journal:  Soc Sci Med       Date:  2014-12-02       Impact factor: 4.634
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.